Selected research
Industry Growth & Trends
Global Gene Knockout Cell Line Construction Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Gene Knockout Cell Line Construction Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Gene Knockout Cell Line Construction Service market include OriGene, Creative Bioarray, Horizon Discovery, Synthego, Cyagen, Cellecta, BiologicsCorp, Kyinno Bio and Porton Advanced, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gene Knockout Cell Line Construction Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gene Knockout Cell Line Construction Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Knockout Cell Line Construction Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Knockout Cell Line Construction Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Gene Knockout Cell Line Construction Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gene Knockout Cell Line Construction Service Market by Company
OriGene
Creative Bioarray
Horizon Discovery
Synthego
Cyagen
Cellecta
BiologicsCorp
Kyinno Bio
Porton Advanced
Cytosurge
AcceGen
System Biosciences
Altogen Labs
Syd Labs
Lifeasible
GenScript
Ubigene
Beyotime
Abace Biotechnology
Viewsolid Biotechnology
iGeneBio
VectorBuilder
BrainVTA
Gene Knockout Cell Line Construction Service Segment by Type
CRISPR/Cas9
TALEN
Others
Gene Knockout Cell Line Construction Service Segment by Application
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Gene Knockout Cell Line Construction Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Knockout Cell Line Construction Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Knockout Cell Line Construction Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Knockout Cell Line Construction Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Gene Knockout Cell Line Construction Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CRISPR/Cas9
- TALEN
- Others
Applications
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
Companies covered
- OriGene
- Creative Bioarray
- Horizon Discovery
- Synthego
- Cyagen
- Cellecta
- BiologicsCorp
- Kyinno Bio
- Porton Advanced
- Cytosurge
- AcceGen
- System Biosciences
- Altogen Labs
- Syd Labs
- Lifeasible
- GenScript
- Ubigene
- Beyotime
- Abace Biotechnology
- Viewsolid Biotechnology
- iGeneBio
- VectorBuilder
- BrainVTA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Gene Knockout Cell Line Construction Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Gene Knockout Cell Line Construction Service Market Size by Region (2021-2032)
- 1.4.1 Global Gene Knockout Cell Line Construction Service Market Size by Region (2021-2026)
- 1.4.2 Global Gene Knockout Cell Line Construction Service Market Size by Region (2027-2032)
- 1.5 Key Regions Gene Knockout Cell Line Construction Service Market Size (2021-2032)
- 1.5.1 North America Gene Knockout Cell Line Construction Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Gene Knockout Cell Line Construction Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Gene Knockout Cell Line Construction Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size Growth Rate (2021-2032)
2 Gene Knockout Cell Line Construction Service Market by Type
- 2.1 Type Introduction
- 2.1.1 CRISPR/Cas9
- 2.1.2 TALEN
- 2.1.3 Others
- 2.2 Global Gene Knockout Cell Line Construction Service Market Size by Type
- 2.2.1 Global Gene Knockout Cell Line Construction Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Gene Knockout Cell Line Construction Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Gene Knockout Cell Line Construction Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Gene Knockout Cell Line Construction Service Market Size by Regions
- 2.3.1 North America Gene Knockout Cell Line Construction Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Gene Knockout Cell Line Construction Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Gene Knockout Cell Line Construction Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Gene Knockout Cell Line Construction Service Market Size Breakdown by Type (2021-2026)
3 Gene Knockout Cell Line Construction Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Academic and Research Institutions
- 3.1.2 Pharmaceutical and Biotechnology Companies
- 3.2 Global Gene Knockout Cell Line Construction Service Market Size by Application
- 3.2.1 Global Gene Knockout Cell Line Construction Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Gene Knockout Cell Line Construction Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Gene Knockout Cell Line Construction Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Gene Knockout Cell Line Construction Service Market Size by Regions
- 3.3.1 North America Gene Knockout Cell Line Construction Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Gene Knockout Cell Line Construction Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Gene Knockout Cell Line Construction Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Gene Knockout Cell Line Construction Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Gene Knockout Cell Line Construction Service Industry Trends
- 4.2 Gene Knockout Cell Line Construction Service Industry Drivers
- 4.3 Gene Knockout Cell Line Construction Service Industry Opportunities and Challenges
- 4.4 Gene Knockout Cell Line Construction Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Gene Knockout Cell Line Construction Service Revenue (2021-2026)
- 5.2 Global Gene Knockout Cell Line Construction Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Gene Knockout Cell Line Construction Service Key Company Headquarters & Area Served
- 5.4 Global Gene Knockout Cell Line Construction Service Company, Product Type & Application
- 5.5 Global Gene Knockout Cell Line Construction Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Gene Knockout Cell Line Construction Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Gene Knockout Cell Line Construction Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Gene Knockout Cell Line Construction Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 OriGene
- 6.1.1 OriGene Company Information
- 6.1.2 OriGene Business Overview
- 6.1.3 OriGene Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 OriGene Gene Knockout Cell Line Construction Service Product Portfolio
- 6.1.5 OriGene Recent Developments
- 6.2 Creative Bioarray
- 6.2.1 Creative Bioarray Company Information
- 6.2.2 Creative Bioarray Business Overview
- 6.2.3 Creative Bioarray Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Creative Bioarray Gene Knockout Cell Line Construction Service Product Portfolio
- 6.2.5 Creative Bioarray Recent Developments
- 6.3 Horizon Discovery
- 6.3.1 Horizon Discovery Company Information
- 6.3.2 Horizon Discovery Business Overview
- 6.3.3 Horizon Discovery Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Horizon Discovery Gene Knockout Cell Line Construction Service Product Portfolio
- 6.3.5 Horizon Discovery Recent Developments
- 6.4 Synthego
- 6.4.1 Synthego Company Information
- 6.4.2 Synthego Business Overview
- 6.4.3 Synthego Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Synthego Gene Knockout Cell Line Construction Service Product Portfolio
- 6.4.5 Synthego Recent Developments
- 6.5 Cyagen
- 6.5.1 Cyagen Company Information
- 6.5.2 Cyagen Business Overview
- 6.5.3 Cyagen Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cyagen Gene Knockout Cell Line Construction Service Product Portfolio
- 6.5.5 Cyagen Recent Developments
- 6.6 Cellecta
- 6.6.1 Cellecta Company Information
- 6.6.2 Cellecta Business Overview
- 6.6.3 Cellecta Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cellecta Gene Knockout Cell Line Construction Service Product Portfolio
- 6.6.5 Cellecta Recent Developments
- 6.7 BiologicsCorp
- 6.7.1 BiologicsCorp Company Information
- 6.7.2 BiologicsCorp Business Overview
- 6.7.3 BiologicsCorp Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 BiologicsCorp Gene Knockout Cell Line Construction Service Product Portfolio
- 6.7.5 BiologicsCorp Recent Developments
- 6.8 Kyinno Bio
- 6.8.1 Kyinno Bio Company Information
- 6.8.2 Kyinno Bio Business Overview
- 6.8.3 Kyinno Bio Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kyinno Bio Gene Knockout Cell Line Construction Service Product Portfolio
- 6.8.5 Kyinno Bio Recent Developments
- 6.9 Porton Advanced
- 6.9.1 Porton Advanced Company Information
- 6.9.2 Porton Advanced Business Overview
- 6.9.3 Porton Advanced Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Porton Advanced Gene Knockout Cell Line Construction Service Product Portfolio
- 6.9.5 Porton Advanced Recent Developments
- 6.10 Cytosurge
- 6.10.1 Cytosurge Company Information
- 6.10.2 Cytosurge Business Overview
- 6.10.3 Cytosurge Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Cytosurge Gene Knockout Cell Line Construction Service Product Portfolio
- 6.10.5 Cytosurge Recent Developments
- 6.11 AcceGen
- 6.11.1 AcceGen Company Information
- 6.11.2 AcceGen Business Overview
- 6.11.3 AcceGen Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AcceGen Gene Knockout Cell Line Construction Service Product Portfolio
- 6.11.5 AcceGen Recent Developments
- 6.12 System Biosciences
- 6.12.1 System Biosciences Company Information
- 6.12.2 System Biosciences Business Overview
- 6.12.3 System Biosciences Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 System Biosciences Gene Knockout Cell Line Construction Service Product Portfolio
- 6.12.5 System Biosciences Recent Developments
- 6.13 Altogen Labs
- 6.13.1 Altogen Labs Company Information
- 6.13.2 Altogen Labs Business Overview
- 6.13.3 Altogen Labs Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Altogen Labs Gene Knockout Cell Line Construction Service Product Portfolio
- 6.13.5 Altogen Labs Recent Developments
- 6.14 Syd Labs
- 6.14.1 Syd Labs Company Information
- 6.14.2 Syd Labs Business Overview
- 6.14.3 Syd Labs Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Syd Labs Gene Knockout Cell Line Construction Service Product Portfolio
- 6.14.5 Syd Labs Recent Developments
- 6.15 Lifeasible
- 6.15.1 Lifeasible Company Information
- 6.15.2 Lifeasible Business Overview
- 6.15.3 Lifeasible Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Lifeasible Gene Knockout Cell Line Construction Service Product Portfolio
- 6.15.5 Lifeasible Recent Developments
- 6.16 GenScript
- 6.16.1 GenScript Company Information
- 6.16.2 GenScript Business Overview
- 6.16.3 GenScript Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 GenScript Gene Knockout Cell Line Construction Service Product Portfolio
- 6.16.5 GenScript Recent Developments
- 6.17 Ubigene
- 6.17.1 Ubigene Company Information
- 6.17.2 Ubigene Business Overview
- 6.17.3 Ubigene Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Ubigene Gene Knockout Cell Line Construction Service Product Portfolio
- 6.17.5 Ubigene Recent Developments
- 6.18 Beyotime
- 6.18.1 Beyotime Company Information
- 6.18.2 Beyotime Business Overview
- 6.18.3 Beyotime Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Beyotime Gene Knockout Cell Line Construction Service Product Portfolio
- 6.18.5 Beyotime Recent Developments
- 6.19 Abace Biotechnology
- 6.19.1 Abace Biotechnology Company Information
- 6.19.2 Abace Biotechnology Business Overview
- 6.19.3 Abace Biotechnology Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Abace Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
- 6.19.5 Abace Biotechnology Recent Developments
- 6.20 Viewsolid Biotechnology
- 6.20.1 Viewsolid Biotechnology Company Information
- 6.20.2 Viewsolid Biotechnology Business Overview
- 6.20.3 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
- 6.20.5 Viewsolid Biotechnology Recent Developments
- 6.21 iGeneBio
- 6.21.1 iGeneBio Company Information
- 6.21.2 iGeneBio Business Overview
- 6.21.3 iGeneBio Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 iGeneBio Gene Knockout Cell Line Construction Service Product Portfolio
- 6.21.5 iGeneBio Recent Developments
- 6.22 VectorBuilder
- 6.22.1 VectorBuilder Company Information
- 6.22.2 VectorBuilder Business Overview
- 6.22.3 VectorBuilder Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 VectorBuilder Gene Knockout Cell Line Construction Service Product Portfolio
- 6.22.5 VectorBuilder Recent Developments
- 6.23 BrainVTA
- 6.23.1 BrainVTA Company Information
- 6.23.2 BrainVTA Business Overview
- 6.23.3 BrainVTA Gene Knockout Cell Line Construction Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 BrainVTA Gene Knockout Cell Line Construction Service Product Portfolio
- 6.23.5 BrainVTA Recent Developments
7 North America
- 7.1 North America Gene Knockout Cell Line Construction Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
- 7.3 North America Gene Knockout Cell Line Construction Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Gene Knockout Cell Line Construction Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
- 8.3 Europe Gene Knockout Cell Line Construction Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Gene Knockout Cell Line Construction Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
- 10.3 South America Gene Knockout Cell Line Construction Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst